Generation of recombinant MVA-norovirus: a comparison study of bacterial artificial chromosome- and marker-based systems

Recombinant Modified Vaccinia Virus Ankara has been employed as a safe and potent viral vector vaccine against infectious diseases and cancer. We generated recMVAs encoding norovirus GII.4 genotype capsid prot...

Source: Virology Journal - August 9, 2019 Category: Virology Authors: Franziska Kugler, Ingo Drexler, Ulrike Protzer, Dieter Hoffmann and Hassan Moeini Tags: Methodology Source Type: research